Miraculins Inc.
6-1250 Waverley Street
Winnipeg
Manitoba
R3T 6C6
Canada
Tel: 204-453-1408
Fax: 204-453-1546
Website: http://www.miraculins.com/
Email: info@miraculins.com
86 articles about Miraculins Inc.
-
Miraculins Inc., Catalyn Medical Technologies Execute $90 Million Scout DS® Pact
8/14/2014
-
Miraculins Inc. Updates Market On Distributor Discussions For Scout DS® Diabetes Screening Test In China
5/2/2014
-
Miraculins Inc. Release: Diabetes In China: Canadian Biotech Aims To Make A Difference
2/6/2014
-
Cachet Signs Term Sheet To Distribute Miraculins Inc.'s Diabetes Device in China
2/4/2014
-
Miraculins Inc. Executes Term Sheet To Appoint Cachet Pharmaceutical As Exclusive Distributor Of The Scout DS® Diabetes Test In China
1/31/2014
-
Miraculins Inc. And Alere Inc. Shift Focus Of Endoglin Program From Sub-License To Supply Agreement
1/31/2014
-
Miraculins Inc. and Cachet Sign LOI for China Rights to Diabetes Test
10/16/2013
-
Miraculins Inc. Outlines Details of PreVu 510(k) FDA Clearance
3/6/2012
-
Miraculins Inc. Appoints Interim CFO, April Manness
7/15/2011
-
Miraculins Inc. Retains Bloom Burton & Co. for Strategic Advisory Services
1/31/2011
-
Miraculins Inc. Announces Preeclampsia Program Advancements by Partner Alere Inc.
1/18/2011
-
Miraculins Inc. Announces Plans to Launch PREVU in Q4 2011
1/11/2011
-
Miraculins Inc. Announces Closing of Private Placement Offering
12/15/2010
-
Miraculins Inc. Announces Private Placement Offering
11/3/2010
-
Miraculins Inc. Announces Appointment of New Executive Team Members
10/4/2010
-
Miraculins Inc. Announces Exercise of Warrants for Proceeds of $850,000
9/21/2010
-
Miraculins Inc. Announces Completion of PREVU Skin Cholesterol Test Acquisition
9/3/2010
-
Miraculins Inc. Announces Accelerated Expiry of Warrants
8/17/2010
-
Miraculins Inc. Launches ELISA Kit for Detection of PSP94 in Urine and Announces Distribution Agreement With GenWay Biotech, Inc.
8/11/2010
-
Miraculins Inc. Executes Final Agreement to Acquire PREVU(TM) Skin Cholesterol Test
8/5/2010